FDA approves Exxua for depression treatment after multiple rejections over more than two decades

FDA approves Exxua for depression treatment after multiple rejections over more than two decades

The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval.  Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side…